126 related articles for article (PubMed ID: 7906856)
1. Release of dopamine via the human transporter.
Eshleman AJ; Henningsen RA; Neve KA; Janowsky A
Mol Pharmacol; 1994 Feb; 45(2):312-6. PubMed ID: 7906856
[TBL] [Abstract][Full Text] [Related]
2. Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux.
Wall SC; Gu H; Rudnick G
Mol Pharmacol; 1995 Mar; 47(3):544-50. PubMed ID: 7700252
[TBL] [Abstract][Full Text] [Related]
3. Induction by low Na+ or Cl- of cocaine sensitive carrier-mediated efflux of amines from cells transfected with the cloned human catecholamine transporters.
Pifl C; Agneter E; Drobny H; Reither H; Singer EA
Br J Pharmacol; 1997 May; 121(2):205-12. PubMed ID: 9154329
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of the dopamine-releasing actions of amphetamine and cocaine: plasmalemmal dopamine transporter versus vesicular monoamine transporter.
Pifl C; Drobny H; Reither H; Hornykiewicz O; Singer EA
Mol Pharmacol; 1995 Feb; 47(2):368-73. PubMed ID: 7870046
[TBL] [Abstract][Full Text] [Related]
5. Dopamine transporter mediated release of dopamine: role of chloride.
Sitges M; Reyes A; Chiu LM
J Neurosci Res; 1994 Sep; 39(1):11-22. PubMed ID: 7807588
[TBL] [Abstract][Full Text] [Related]
6. Effects of methamphetamine and lobeline on vesicular monoamine and dopamine transporter-mediated dopamine release in a cotransfected model system.
Wilhelm CJ; Johnson RA; Lysko PG; Eshleman AJ; Janowsky A
J Pharmacol Exp Ther; 2004 Sep; 310(3):1142-51. PubMed ID: 15102929
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase-mediated bidirectional trafficking and functional regulation of the human dopamine transporter.
Pristupa ZB; McConkey F; Liu F; Man HY; Lee FJ; Wang YT; Niznik HB
Synapse; 1998 Sep; 30(1):79-87. PubMed ID: 9704884
[TBL] [Abstract][Full Text] [Related]
8. WIN 35,428 and mazindol are mutually exclusive in binding to the cloned human dopamine transporter.
Xu C; Reith ME
J Pharmacol Exp Ther; 1997 Aug; 282(2):920-7. PubMed ID: 9262359
[TBL] [Abstract][Full Text] [Related]
9. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter.
Giros B; el Mestikawy S; Godinot N; Zheng K; Han H; Yang-Feng T; Caron MG
Mol Pharmacol; 1992 Sep; 42(3):383-90. PubMed ID: 1406597
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological heterogeneity of the cloned and native human dopamine transporter: disassociation of [3H]WIN 35,428 and [3H]GBR 12,935 binding.
Pristupa ZB; Wilson JM; Hoffman BJ; Kish SJ; Niznik HB
Mol Pharmacol; 1994 Jan; 45(1):125-35. PubMed ID: 8302271
[TBL] [Abstract][Full Text] [Related]
11. Cationic modulation of human dopamine transporter: dopamine uptake and inhibition of uptake.
Chen N; Trowbridge CG; Justice JB
J Pharmacol Exp Ther; 1999 Sep; 290(3):940-9. PubMed ID: 10454463
[TBL] [Abstract][Full Text] [Related]
12. Catecholamine transporters and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity: studies comparing the cloned human noradrenaline and human dopamine transporter.
Pifl C; Hornykiewicz O; Giros B; Caron MG
J Pharmacol Exp Ther; 1996 Jun; 277(3):1437-43. PubMed ID: 8667208
[TBL] [Abstract][Full Text] [Related]
13. 3'-Chloro-3 alpha-(diphenylmethoxy)tropane but not 4'-chloro-3 alpha-(diphenylmethoxy)tropane produces a cocaine-like behavioral profile.
Kline RH; Izenwasser S; Katz JL; Joseph DB; Bowen WD; Newman AH
J Med Chem; 1997 Mar; 40(6):851-7. PubMed ID: 9083473
[TBL] [Abstract][Full Text] [Related]
14. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter.
Giros B; Jaber M; Jones SR; Wightman RM; Caron MG
Nature; 1996 Feb; 379(6566):606-12. PubMed ID: 8628395
[TBL] [Abstract][Full Text] [Related]
15. Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.
Ukairo OT; Bondi CD; Newman AH; Kulkarni SS; Kozikowski AP; Pan S; Surratt CK
J Pharmacol Exp Ther; 2005 Aug; 314(2):575-83. PubMed ID: 15879005
[TBL] [Abstract][Full Text] [Related]
16. In vivo dopamine clearance rate in rat striatum: regulation by extracellular dopamine concentration and dopamine transporter inhibitors.
Zahniser NR; Larson GA; Gerhardt GA
J Pharmacol Exp Ther; 1999 Apr; 289(1):266-77. PubMed ID: 10087014
[TBL] [Abstract][Full Text] [Related]
17. Intracellular Ca2+ regulates amphetamine-induced dopamine efflux and currents mediated by the human dopamine transporter.
Gnegy ME; Khoshbouei H; Berg KA; Javitch JA; Clarke WP; Zhang M; Galli A
Mol Pharmacol; 2004 Jul; 66(1):137-43. PubMed ID: 15213305
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of dopamine transporter after chronic self-administration of bupropion and nomifensine.
Tella SR; Ladenheim B; Cadet JL
J Pharmacol Exp Ther; 1997 Apr; 281(1):508-13. PubMed ID: 9103538
[TBL] [Abstract][Full Text] [Related]
19. The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter.
Jayanthi LD; Apparsundaram S; Malone MD; Ward E; Miller DM; Eppler M; Blakely RD
Mol Pharmacol; 1998 Oct; 54(4):601-9. PubMed ID: 9765501
[TBL] [Abstract][Full Text] [Related]
20. Tolerance in the replacement of the benzhydrylic O atom in 4-[2-(diphenylmethoxy)ethyl]-1-benzylpiperidine derivatives by an N atom: development of new-generation potent and selective N-analogue molecules for the dopamine transporter.
Dutta AK; Xu C; Reith ME
J Med Chem; 1998 Aug; 41(17):3293-7. PubMed ID: 9703474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
